2021
DOI: 10.3389/fcell.2021.735374
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

Abstract: Sarcopenia is an age-related disease in which muscle mass, strength and function may decline with age or can be secondary to cachexia or malnutrition and can lead to weakness, falls and even death. With the increase in life expectancy, sarcopenia has become a major threat to the health of the elderly. Currently, our understanding of bone-muscle interactions is not limited to their mechanical coupling. Bone and muscle have been identified as secretory endocrine organs, and their interaction may affect the funct… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(26 citation statements)
references
References 163 publications
(195 reference statements)
0
21
0
Order By: Relevance
“…Meanwhile, treatments for atherosclerosis such as angiotensin receptor blockers improve bone strength [140]. These results partly suggest that risk factors are shared among atherosclerosis, osteoporosis, and sarcopenia and indicate that an integrated approach to the whole system may be effective for prevention of these disease conditions [141,142]. One of the promising therapeutic approaches may be nutritional support with exercise, as described previously (143,144).…”
Section: The Concept Of a Blood Vessel/heart-boneskeletal Muscle Axis...mentioning
confidence: 78%
“…Meanwhile, treatments for atherosclerosis such as angiotensin receptor blockers improve bone strength [140]. These results partly suggest that risk factors are shared among atherosclerosis, osteoporosis, and sarcopenia and indicate that an integrated approach to the whole system may be effective for prevention of these disease conditions [141,142]. One of the promising therapeutic approaches may be nutritional support with exercise, as described previously (143,144).…”
Section: The Concept Of a Blood Vessel/heart-boneskeletal Muscle Axis...mentioning
confidence: 78%
“…[225] Receptor activator of NF-κB ligand RANKL Inhibits muscle mass and function. [181] Wnt family member 3a Wnt3a Wnt3a accelerates C2C12 differentiation. [220] Prostaglandin E2 PGE2 Mimics specific effects of the osteocyte-secreted factors on the process of myogenesis and also the muscle function.…”
Section: Undercarboxylated Osteocalcin Ucocnmentioning
confidence: 99%
“…As previously described, OCN is the most abundant noncollagen protein secreted in a carboxylated form solely in osteoblasts. Because of its low pH and decarboxylation, it may be released into the blood circulation [ 181 ]. OCN also stimulates the synthesis of IL-6 [ 210 ].…”
Section: Musculoskeletal Crosstalkmentioning
confidence: 99%
“…A low OPG/RANKL ratio is present in patients with RA compared to healthy patients and is associated with increased radiographic damage and joint and bone destruction in RA. In this sense, the RANKL/OPG relationship plays an essential role in regulating bone homeostasis in RA, and changes in this relationship may be a protective mechanism against accelerated bone loss in RA [ 47 , 51 , 52 , 53 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 ].…”
Section: General Aspects Of Ra and The Role Of Myokines Osteokines Ad...mentioning
confidence: 99%
“…Age, stage of the disease, and several other factors influence the levels of OPG, justifying such discrepant results between studies. Furthermore, autoantibodies to osteoprotegerin are associated with increased bone resorption in RA, with OPG antibody-positive patients having longer disease duration and activity and higher levels of bone resorption markers [ 66 , 67 , 70 , 71 , 72 ].…”
Section: General Aspects Of Ra and The Role Of Myokines Osteokines Ad...mentioning
confidence: 99%